Rare bone disease related to a common gene or pathway defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:364803
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare bone disease related to a common gene or pathway defect (Orphanet code 364803) is a broad grouping term used to describe a collection of uncommon bone disorders that share underlying genetic or molecular pathway problems with more well-known conditions. These diseases affect how bones grow, develop, maintain their strength, or repair themselves. Because they involve genes or signaling pathways that are also linked to more common bone conditions, researchers sometimes group them together to better understand shared biology. Patients with these conditions may experience a range of bone-related problems, including bones that break easily, abnormal bone shape or density, short stature, joint problems, and chronic bone pain. The severity can vary widely depending on the specific condition and the exact genetic change involved. Some individuals may have mild symptoms noticed only in adulthood, while others may show signs from birth or early childhood. The treatment landscape for these rare bone diseases is largely supportive and symptom-based. Management may include medications to strengthen bones (such as bisphosphonates), physical therapy, orthopedic surgery to correct bone deformities or stabilize fractures, pain management, and nutritional support including calcium and vitamin D supplementation. Because these are rare conditions, care is best coordinated through specialized bone disease or genetics centers. Research into targeted therapies based on the specific pathway defects is ongoing, offering hope for more precise treatments in the future.

Key symptoms:

Bones that break easily or frequentlyAbnormal bone shape or bowing of the limbsShort stature or growth problemsChronic bone painLow bone density (weak bones)Joint stiffness or limited range of motionBone deformities visible at birth or developing over timeDifficulty walking or problems with mobilityDelayed bone healing after fracturesDental problems such as brittle or discolored teethSpinal curvature (scoliosis or kyphosis)Fatigue and reduced endurance

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare bone disease related to a common gene or pathway defect.

View clinical trials →

No actively recruiting trials found for Rare bone disease related to a common gene or pathway defect at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare bone disease related to a common gene or pathway defect community →

No specialists are currently listed for Rare bone disease related to a common gene or pathway defect.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare bone disease related to a common gene or pathway defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare bone disease related to a common gene or pathway defectForum →

No community posts yet. Be the first to share your experience with Rare bone disease related to a common gene or pathway defect.

Start the conversation →

Latest news about Rare bone disease related to a common gene or pathway defect

No recent news articles for Rare bone disease related to a common gene or pathway defect.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact diagnosis, and which gene or pathway is involved in my condition?,What treatments are available to strengthen my bones and reduce fracture risk?,How often should I have bone density scans and other monitoring tests?,Are there any clinical trials or new therapies I should know about?,What physical activities are safe for me, and which should I avoid?,Should my family members be tested for this condition?,What specialists should be part of my care team, and how often should I see them?

Common questions about Rare bone disease related to a common gene or pathway defect

What is Rare bone disease related to a common gene or pathway defect?

Rare bone disease related to a common gene or pathway defect (Orphanet code 364803) is a broad grouping term used to describe a collection of uncommon bone disorders that share underlying genetic or molecular pathway problems with more well-known conditions. These diseases affect how bones grow, develop, maintain their strength, or repair themselves. Because they involve genes or signaling pathways that are also linked to more common bone conditions, researchers sometimes group them together to better understand shared biology. Patients with these conditions may experience a range of bone-rel